Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
During this webinar, experts will:
This podcast details how Renu Juneja went from earning a PhD in the pharmaceutical industry to becoming a medical writer at Novo Nordisk.
Empower Medical Affairs and Deliver Impact — We focus on strengthening the bridge between clinical and commercial, drawing from our foundation of scientific knowledge, regulatory expertise, and industry experience. By promoting innovation and best practices through this multi-stakeholder approach, we can help your team Deliver effective medical strategies, cross-functional communication plans, and programs to connect with patients and providers.
Standards and Guidance powerpoint and templates for Medical Affairs strategic planning
Lockwood collaborates with clients in the pharmaceutical, biotech, and medical device industries to identify effective, holistic, science-based strategies to address their Med Affairs and Publications objectives through medical and market access communications.
This paper synthesizes the views of senior global Medical Affairs leaders to provide a unified vision for the future of Medical Affairs. As such, this document represents the first consensus position by executives in Medical Affairs of our evolving roles, activities, and value in society, industry, teams and as individuals (detailing each in turn). By 2030, Medical Affairs will solidify its transition from executional to strategic, and the function will come to represent the voice of the patient within industry. We will not only disseminate evidence but also lead evidence generation activities that inform the real-world use of marketed and emerging treatments. Also in this time frame, we will solidify the role of Medical Affairs as industry’s external earpiece, gleaning insights from our interactions with the health care ecosystem that drive understanding of patient, payer, and provider needs and opinions. Throughout this evolution, the true north of Medical Affairs remains the same: to ensure that our science and technologies benefit patients.
Demonstrating value and providing insights to help clients excel in the competitive and evolving healthcare landscapes
The landscape for Medical Affairs is rapidly changing. The end customer experience has become much more critical than ever before. Hence, assessing the evolving needs and preferences of customers is a top priority for Medical Affairs leaders today. Given the non-promotional nature of Medical Affairs, solving this problem is a very complex process as the impact of engagements cannot be tied back to any ROI-based metrics. But from a futuristic perspective, it is imperative to ensure that for medical engagements, the right content is available from the right source via the right channel. Hence there is a strong need for approaches that help reimagine the overall customer engagement strategy for Medical Affairs via clearly articulated plans to address the unique needs of well-defined customer segments, thus enabling positive customer experiences. Such focused approaches will help redefine engagements for Medical Affairs organizations and clearly articulate the needs and experience drivers for stakeholders. The outcomes will enable medical teams to look beyond the static KOL tiers and design KOL archetypes or personas based their unique needs.
This webinar will tackle questions around how customer engagement is being approached as of today and help redefine the industry thinking on this important topic for Medical Affairs, especially in the hybrid engagement model of the future. Plus, it will also try to establish a foundation for Medical Affairs groups to develop customer-segmentation-enabled go-to market strategies.
This podcast details the need for content curation to cut through the noise — and eventually provide patient benefit.
This webinar will provide an overview of the evolution of the Medical Affairs role and contributions to scientific congresses. We will revisit the good old days of in person congress engagement pivoting to highlight the innovations scientific exchange today. We will also discuss the elements of transitioning to a completely virtual platform due to the COVID-19 pandemic which provided an opportunity to re-evaluate the medical affairs approach. Which activities and educational resources were of high-value and could be improved upon further? Lastly, we will touch upon future congresses experiences. What will HCP engagement consist of– live, virtual, hybrid, etc. Based upon these new opportunities are our metrics and KPIs effective?
1. Identify opportunities to leverage the congress experience to enhance scientific exchange
2. Explore strategies to harmonize in-person and digital medical affairs engagement
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.